| Field | Specification |
|---|---|
| Target | |
| Alternative names | Pentraxin-related protein PTX3|Pentaxin-related protein PTX3|Tumor necrosis factor alpha-induced protein 5|TNF alpha-induced protein 5|Tumor necrosis factor-inducible gene 14 protein|TSG-14|PTX3|TNFAIP5|TSG14 |
| UniProt # | |
| Species | |
| Reactivity | |
| Applications | |
| Sample type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Detection range | |
| Detection method | |
| Assay time | |
| Storage | |
| Catalog no. (Mfr.) | |
| Main SKU |
Background
human PTX3 (Pentraxin 3) is a molecular target commonly studied in immunology, cardiovascular, and cancer research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of PTX3 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of PTX3 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
PTX3 (Pentraxin 3) may also be referenced as Pentraxin-related protein PTX3, Pentaxin-related protein PTX3, and Tumor necrosis factor alpha-induced protein 5 in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how PTX3 relates to innate and adaptive immune responses, cytokine signaling networks, host–pathogen interactions, and immune cell activation and trafficking in immunology, cardiovascular, and cancer research.
- Interpreting shifts in PTX3 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
PTX3 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with immunology, cardiovascular, and cancer studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
The role of pentraxin 3 and oxidative status in the prognosis of multiple myeloma
IF: 2.5 Journal: Journal of Investigative Medicine Author: Department of Medical Biochemistry, Faculty of Medicine, Hatay Mustafa Kemal University, Hatay, Turkey Cited Date: 2024-06-28
The effect of aerobic and high-intensity interval training on plasma pentraxin 3 and lipid parameters in overweight and obese women
IF: 2.3 Journal: PeerJ Author: Faculty of Sports Sciences, Hitit University, Corum, Turkey. Cited Date: 2024-10-08
Pentraxins 3 levels in pregnant women diagnosed with preeclampsia and their relationship with the severity of the condition
IF: 1.4 Journal: Journal of Perinatal Medicine Author: Obstetrics and Gynecology Department, Umraniye Training and Research Hospital, Istanbul, Türkiye Cited Date: 2025-10-17
Significance of myeloperoxidase, pentraxin-3 and soluble urokinase plasminogen activator receptor determination in patients with moderate carotid artery stenosis
IF: 1.3 Journal: Scandinavian Journal of Clinical and Laboratory Investigation Author: Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia. Cited Date: 2024-11-15
KORELASI ANTARA KADAR PLASMA PENTRAXIN 3 DENGAN PARAMETER EKOKARDIOGRAFI FUNGSI DIASTOLIK VENTRIKEL KIRI (RASIO E/e’) PADA PASIEN GAGAL JANTUNG DENGAN FRAKSI EJEKSI NORMAL
IF: Journal: IR-PERPUSTAKAAN UNIVERSITAS AIRLANGGA Cited Date: 2018-01-08
SERUM NT- PRO-ATRIAL NATRIURETIC PEPTIDE AND PENTRAXIN 3 AS COMPARATIVE TO ROUTINE CARDIAC FUNCTIONS TESTS IN DIABETIC PATIENTS WITH MYOCARDIAL INFARCTION
IF: Journal: INT. J. BIOL. BIOTECH Cited Date: 2019-10-05